-$0.73 Earnings Per Share Expected for Inspire Medical Systems, Inc. (NYSE:INSP) This Quarter

Wall Street brokerages expect Inspire Medical Systems, Inc. (NYSE:INSPGet Rating) to report earnings of ($0.73) per share for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Inspire Medical Systems’ earnings, with the lowest EPS estimate coming in at ($0.90) and the highest estimate coming in at ($0.47). Inspire Medical Systems posted earnings of ($0.60) per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 21.7%. The firm is scheduled to announce its next quarterly earnings results after the market closes on Monday, January 1st.

On average, analysts expect that Inspire Medical Systems will report full-year earnings of ($1.95) per share for the current financial year, with EPS estimates ranging from ($2.69) to ($0.01). For the next financial year, analysts forecast that the company will report earnings of ($1.03) per share, with EPS estimates ranging from ($2.06) to $1.01. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Inspire Medical Systems.

Inspire Medical Systems (NYSE:INSPGet Rating) last posted its quarterly earnings data on Tuesday, February 8th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.35. The business had revenue of $78.40 million for the quarter, compared to analyst estimates of $75.60 million. Inspire Medical Systems had a negative net margin of 18.01% and a negative return on equity of 18.84%. Inspire Medical Systems’s quarterly revenue was up 70.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.28) earnings per share.

A number of equities analysts recently weighed in on the stock. Bank of America initiated coverage on shares of Inspire Medical Systems in a research report on Wednesday, March 2nd. They set a “buy” rating for the company. Wolfe Research assumed coverage on shares of Inspire Medical Systems in a report on Tuesday, April 5th. They issued a “market perform” rating and a $270.00 price target on the stock. Zacks Investment Research cut shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, January 26th. Finally, SVB Leerink lifted their target price on shares of Inspire Medical Systems from $270.00 to $273.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 9th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $288.00.

Shares of INSP stock opened at $255.88 on Friday. Inspire Medical Systems has a 12 month low of $159.18 and a 12 month high of $286.29. The company has a 50 day simple moving average of $235.79 and a two-hundred day simple moving average of $238.25. The company has a quick ratio of 6.08, a current ratio of 6.50 and a debt-to-equity ratio of 0.07.

In other Inspire Medical Systems news, Director Marilyn C. Nelson sold 10,000 shares of the company’s stock in a transaction dated Friday, April 1st. The stock was sold at an average price of $267.50, for a total value of $2,675,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Timothy P. Herbert sold 20,000 shares of Inspire Medical Systems stock in a transaction on Thursday, March 17th. The stock was sold at an average price of $225.40, for a total transaction of $4,508,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 52,143 shares of company stock valued at $12,848,826. 5.00% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Diversified Trust Co increased its holdings in Inspire Medical Systems by 18.7% in the first quarter. Diversified Trust Co now owns 4,130 shares of the company’s stock worth $1,060,000 after purchasing an additional 650 shares in the last quarter. Norges Bank bought a new stake in shares of Inspire Medical Systems during the 4th quarter valued at $48,850,000. BlackRock Inc. increased its stake in Inspire Medical Systems by 2.1% in the 4th quarter. BlackRock Inc. now owns 1,846,227 shares of the company’s stock worth $424,741,000 after acquiring an additional 38,582 shares during the last quarter. EFG Asset Management North America Corp. purchased a new position in shares of Inspire Medical Systems in the 4th quarter worth about $2,655,000. Finally, California State Teachers Retirement System raised its holdings in shares of Inspire Medical Systems by 2.5% during the fourth quarter. California State Teachers Retirement System now owns 37,731 shares of the company’s stock valued at $8,680,000 after acquiring an additional 910 shares in the last quarter. 93.09% of the stock is owned by institutional investors.

About Inspire Medical Systems (Get Rating)

Inspire Medical Systems, Inc engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead.

Featured Stories

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.